A study carried out through the use of systems biology, with the analysis of complex data, starting with omics data and using integrative tools for the analysis of dynamic and modular responses, has identified a candidate target and the use of its inhibitor as new useful drug to combat Alzheimer's disease. The present invention refers to the total or partial inhibition of the expression of the localized gene, or of the activity of the enzyme encoded by said gene, to be used for the treatment of Alzheimer's disease.
Alzheimer's disease is recognized as one of the most important medical-social problems that affects our society and whose treatment is, to date, fundamentally symptomatic. The drugs currently used usually improve neuropsychiatric symptoms, such as agitation or depression that appear during the evolution of the disease, and although they improve the quality of life of the patient and their close environment for a time, they do not effectively modify the cognitive deterioration that accompanies the evolution of the disease.
In the present study, through the use of systems biology, with the analysis of complex data, starting with omics data and using integrative tools for the analysis of dynamic and modular responses, a candidate target and the use of its inhibitor have been identified as new useful drug to fight Alzheimer's disease.
This inhibitor was tested in an Alzheimer model of Caenorhabditis elegans, showing a significant improvement in the phenotype and indicating its use as a new drug for the treatment of this disease. This candidate drug has been widely used in humans for the treatment of cancer, but in the quantities tested it did not exert a significant effect on the cell cycle, nor did it affect cell viability in vitro when analyzed in the microglia cell line, therefore the Reuse of this drug is presented as an effective method for the treatment of neurodegenerative diseases and a promising candidate for reuse in Alzheimer's disease.
Current development status
Applications in the field of health sciences, specifically in the therapeutic area. Candidates for drugs for the treatment of Alzheimer's disease.
Desired business relationship